Table 2.
Determination of predictive factors for long‐term survival of gastric adenocarcinoma patients with curative surgical resection by univariate analysis
| Valuables | n | Relative risk (95% CI) | P‐values |
|---|---|---|---|
| Age | |||
| < 60 years | 12 | 1 | |
| ≧60 years | 59 | 1.00 (0.97–1.04) | NS |
| Gender | |||
| Female | 22 | 1 | |
| Male | 49 | 1.18 (0.54–2.58) | NS |
| Histological type | |||
| Tubular | 39 | 1 | |
| Poorly | 32 | 1.38 (0.68–2.79) | NS |
| Gastric cancer stage | |||
| Stage I | 16 | 1 | |
| Stage II | 15 | 1.16 (0.07–18.46) | NS |
| Stage III | 19 | 13.10 (1.67–102.92) | <0.01 |
| Stage IV | 21 | 49.26 (6.40–379.41) | <0.01 |
| Expression of 15‐PGDH in tumor tissue | |||
| Positive | 36 | 1 | |
| Negative | 35 | 3.50 (1.59–6.63) | 0.02 |
| Expression of COX‐2 in tumor tissue | |||
| Positive | 48 | 1 | |
| Negative | 23 | 1.69 (0.81–3.52) | NS |
15‐PGDH, 15‐hydroxyprostaglandin dehydrogenase; CI, confidence interval; COX‐2, cyclooxygenase‐2; NS, not significant; poorly, poorly differentiated adenocarcinoma; tubular, tubular adenocarcinoma.